Axiora Medical
The global arthroscopic equipment market is undergoing a paradigm shift driven by the demand for minimally invasive surgery (MIS). As aging populations increase, the necessity for high-precision joint repair tools—specifically in ACL reconstruction and meniscal repair—has escalated. Axiora leads this trend by integrating Industry 4.0 standards, ensuring that every instrument meets the strict biocompatibility and durability requirements of modern orthopedic clinics.
China's manufacturing ecosystem has evolved from high-volume production to high-tech innovation. Axiora's 18,600m² facility embodies this evolution. By utilizing Automated CNC systems and stringent OQC protocols, we provide global distributors with a resilient supply chain capable of rapid prototyping and mass-scale production without compromising quality.
| Attribute | Data |
|---|---|
| Industry Experience | 15 Years |
| Quality Control Staff | 48 Professionals |
| R&D Engineers | 86 Specialists |
| Annual Export Revenue | USD 26 Million |
We combine 15 years of R&D with 100% finished product inspection to ensure Class III medical device compliance.
Yes, we provide full customization from logo printing to material selection based on your technical drawings.
Through advanced CMM, hardness testing, and salt spray testing in our state-of-the-art facility.